Sign in
4

Changes in Ownership

Protalix BioTherapeutics, Inc. Filed Acc 0001393043-07-000001

Options or other derivatives

  • VP of Operations acquired 204,351 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Katz Iftah · VP of Operations

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2007-05-15 Grant or award : show line 1 in the form Stock Options (Right to Buy) +204,351 204,351 D
Loading xslF345X02/primary_doc.xml…